DERMTECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.595 USD | -1.34% |
|
-0.12% | -66.00% |
| 22/04 | North American Morning Briefing : Stock Futures -2- | DJ |
| 19/04 | Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63 | MT |
Chart calendar DermTech, Inc.
8f26ffbbb9e84181cb36867ef6180.fGgVSbHues7XyCM3oo5_xm0lWsP18kXnyL32cuWfNmw.CwpaE_mISpyiinVB9sRPpT9gbfaZpHOErISpBJDFcDlLCyR6_qMtmriHZg~63823dff6d51f6132c7ceef40fd5656c
Upcoming events on DermTech, Inc.
Past events on DermTech, Inc.
| 08/03/2024 | American Academy of Dermatology Meeting |
| 01/03/2024 03:30 am | Q4 2023 Earnings Call |
| 01/03/2024 02:31 am | Q4 2023 Earnings Release |
| 03/11/2023 02:30 am | Q3 2023 Earnings Call |
| 03/11/2023 01:31 am | Q3 2023 Earnings Release |
| 04/08/2023 02:30 am | Q2 2023 Earnings Call |
| 04/08/2023 01:31 am | Q2 2023 Earnings Release |
| 01/06/2023 02:00 am | Annual General Meeting |
| 05/05/2023 02:30 am | Q1 2023 Earnings Call |
| 05/05/2023 01:31 am | Q1 2023 Earnings Release |
| 17/03/2023 | American Academy of Dermatology Meeting |
| 14/03/2023 07:30 pm | Oppenheimer Healthcare Conference |
| 09/03/2023 12:00 am | Cowen Health Care Conference |
| 03/03/2023 03:30 am | Q4 2022 Earnings Call |
| 03/03/2023 02:31 am | Q4 2022 Earnings Release |
| 04/11/2022 02:30 am | Q3 2022 Earnings Call |
| 04/11/2022 01:31 am | Q3 2022 Earnings Release |
| 28/09/2022 | Outsourcing in Clinical Trials Southern California Event |
| 09/08/2022 02:30 am | Interim 2022 Earnings Call |
| 09/08/2022 01:31 am | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,36 2,85 18.04% | 5,89 5,73 2.65% | 11,8 12,0 -1.2% | 14,5 14,1 3.14% | 15,3 15,4 -0.6% | 16,8 |
|
EBITDA Million USD | Released Forecast Spread | -17,5 -16,7 -5.01% | -34,8 -36,0 3.33% | -76,4 -71,6 -6.78% | -117 -116 -0.72% | -102 -96,6 -5.5% | -68,6 |
|
EBIT Million USD | Released Forecast Spread | -17,6 -16,8 -5.04% | -35,3 -36,2 2.54% | -77,4 -73,3 -5.61% | -118 -119 0.36% | -104 -104 -0.14% | -79,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -35,2 -36,5 3.54% | -78,3 -74,3 -5.48% | -117 -118 0.91% | -101 -101 0.42% | -77,3 |
|
Net income Million USD | Released Forecast Spread | -19,7 -19,3 -1.8% | -35,2 -36,2 2.59% | -78,3 -74,4 -5.25% | -117 -118 0.72% | -101 -101 0.1% | -77,3 |
|
EPS USD | Released Forecast Spread | -2,81 -3,10 9.35% | -2,08 -2,15 3.44% | -2,71 -2,57 -5.27% | -3,88 -3,92 0.91% | -3,09 -3,11 0.77% | -2,21 |
| Announcement Date | 11/03/20 | 04/03/21 | 01/03/22 | 02/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,17 3,33 -4.9% | 3,72 3,72 0.04% | 4,23 4,81 -12.05% | 3,57 4,67 -23.41% | 2,99 2,56 16.84% | 3,48 3,47 0.1% | 3,98 3,69 7.88% | 3,92 3,90 0.41% | 3,92 4,03 -2.68% | 3,93 | 4,17 | 4,30 | 4,47 | 4,60 |
|
EBITDA Million USD | Released Forecast Spread | -26,0 -21,3 -22.43% | -29,8 -26,2 -14.03% | -29,4 -29,7 0.71% | -28,8 -29,4 1.9% | -28,4 -27,9 -2.09% | -31,6 -26,1 -20.99% | -31,7 -26,3 -20.39% | -19,4 -21,6 10.35% | -19,3 -17,8 -8.48% | -20,4 | -18,3 | -18,2 | -18,2 | -17,7 |
|
EBIT Million USD | Released Forecast Spread | -26,4 -22,2 -18.56% | -30,2 -26,2 -15.32% | -29,8 -30,5 2.09% | -29,3 -30,0 2.49% | -28,9 -29,3 1.45% | -32,0 -28,4 -12.94% | -32,1 -30,6 -5.03% | -19,8 -25,2 21.47% | -19,8 -19,9 0.6% | -20,7 | -19,4 | -19,5 | -19,5 | -19,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,1 -22,3 -16.74% | -30,1 -26,7 -12.9% | -29,6 -30,3 2.24% | -28,8 -29,9 3.7% | -28,2 -29,2 3.38% | -31,3 -28,7 -9.06% | -31,4 -30,1 -4.2% | -19,2 -24,5 21.71% | -19,1 -19,5 2.17% | -20,1 | -19,0 | -19,1 | -19,2 | -19,1 |
|
Net income Million USD | Released Forecast Spread | -26,1 -22,1 -17.65% | -30,1 -26,1 -15.18% | -29,6 -30,4 2.72% | -28,8 -29,9 3.63% | -28,2 -29,1 3.04% | -31,3 -28,1 -11.43% | -31,4 -30,5 -2.75% | -19,2 -24,7 22.36% | -19,1 -19,4 1.65% | -20,2 | -19,0 | -19,0 | -19,1 | -19,1 |
|
EPS USD | Released Forecast Spread | -0,88 -0,74 -18.69% | -1,01 -0,89 -13.7% | -0,99 -1,01 2.39% | -0,96 -0,99 3.03% | -0,93 -0,96 3.41% | -1,02 -0,91 -12.44% | -0,99 -0,97 -1.71% | -0,57 -0,76 24.83% | -0,54 -0,57 4.59% | -0,58 | -0,54 | -0,54 | -0,54 | -0,54 |
| Announcement Date | 01/03/22 | 03/05/22 | 08/08/22 | 03/11/22 | 02/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 29/02/24 | - | - | - | - | - |
| Today 01:35 am | 10X GENOMICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | MYRIAD GENETICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 04:30 pm | LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | DIASORIN S.P.A.: Q1 2024 Earnings Release |
| 13/05/2024 | SD BIOSENSOR, INC: Q1 2024 Earnings Release (Projected) |
| 17/07/2024 11:30 am | VITROLIFE AB: Q2 2024 Earnings Release |
| 30/07/2024 | AMOY DIAGNOSTICS CO., LTD.: Q2 2024 Earnings Release (Projected) |
| 01/08/2024 | MYRIAD GENETICS, INC.: Q2 2024 Earnings Release (Projected) |
| 01/08/2024 | LANTHEUS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for DermTech, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DMTK Stock
- Calendar DermTech, Inc.
